Transoma, maker of cardiovascular monitoring and diagnostic products, landed $5 million in fourth-round funding from United Therapeutics, Affinity Capital Management, Canaan Partners, Cross Creek Capital and Polaris Venture Partners, reports VentureWire. The money comes after the company withdrew its filing to go public earlier this year.